Pseudomonas aeruginosa PAO 1 In Vitro Time–Kill Kinetics Using Single Phages and Phage Formulations—Modulating Death, Adaptation, and Resistance

Pseudomonas aeruginosa is responsible for nosocomial and chronic infections in healthcare settings. The major challenge in treating P. aeruginosa-related diseases is its remarkable capacity for antibiotic resistance development. Bacteriophage (phage) therapy is regarded as a possible alternative tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinto, Ana Mafalda, Faustino, Alberta, Pastrana, Lorenzo M., Bañobre-López, Manuel, Sillankorva, Sanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300829/
https://www.ncbi.nlm.nih.gov/pubmed/34356798
http://dx.doi.org/10.3390/antibiotics10070877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300829/
https://www.ncbi.nlm.nih.gov/pubmed/34356798
http://dx.doi.org/10.3390/antibiotics10070877

Ejemplares similares